Trident Texofab standalone net profit declines 22.09% in the March 2022 quarter

Sales rise 28.46% to Rs 24.51 crore

Net profit of Trident Texofab declined 22.09% to Rs 0.67 crore in the quarter ended March 2022 as against Rs 0.86 crore during the previous quarter ended March 2021. Sales rose 28.46% to Rs 24.51 crore in the quarter ended March 2022 as against Rs 19.08 crore during the previous quarter ended March 2021.

For the full year,net profit rose 180.00% to Rs 0.98 crore in the year ended March 2022 as against Rs 0.35 crore during the previous year ended March 2021. Sales rose 68.82% to Rs 84.29 crore in the year ended March 2022 as against Rs 49.93 crore during the previous year ended March 2021.

ParticularsQuarter EndedYear EndedMar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales24.5119.08 28 84.2949.93 69 OPM %2.905.24 -5.685.75 - PBDT0.591.62 -64 2.701.87 44 PBT0.241.35 -82 1.230.85 45 NP0.670.86 -22 0.980.35 180

Powered by Capital Market - Live News